News Center

May 25, 2022

Spotlight on Fragile X syndrome

Fragile X syndrome (FXS) is one of the most common heritable forms of intellectual disability, occurring in approximately 1 in...
April 29, 2022

Company Spotlight Series: Nizan Stern Braun

I immediately started searching for an external course that would provide me the opportunity to be promoted to the business...
April 22, 2022

Getting to a Lifetime Genetic Textbook for Treating Disease

  • By Haim Neerman
  • Posted in Article
As a society, how much should be invested in creating a “transformative textbook of medicine, with insights that will give...
February 25, 2022

Jansen’s Story

Edited by Kyle W. Davis, CGC and Marimac Moore In honor of Rare Disease Day 2022, we want to introduce...
February 25, 2022

Company Spotlight Series: Lucy Kaplun

As I reflect back, I don’t feel that this one decision determined my career necessarily. It was actually the  exciting...
February 12, 2022

Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding

Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
December 14, 2021

Variantyx Winter Holiday Hours of Operation

Valued Customers, We would like to update you on our winter holiday hours of operation:  Our offices will be closed...
November 12, 2021

Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment

STUTTGART, Germany, Nov. 15, 2021  PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...
August 31, 2021

ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing

ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing. ...
May 11, 2021

Variantyx Expands Into Prenatal, Cancer Testing

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...